Guest guest Posted May 24, 2005 Report Share Posted May 24, 2005 well I guess if Monsanto says its ok then it must be........NOT!!... who do they think they are fooling? Craig USA: May 24, 2005 KANSAS CITY - Monsanto Co. on Monday discounted as insignificant European reports that the company's internal research had found variations in the health of rats fed Monsanto's biotech corn. The furor concerns a type of corn that has been genetically altered to protect itself against corn rootworm. The Monsanto study found that rats fed the biotech corn had smaller kidneys and blood composition different from rats not fed the corn. But Monsanto said the research, which has sparked alarm among some European scientists and government officials, is not evidence of any hidden dangers in its technology. The study reflects only inconsequential differences in kidney size and blood composition in the animals used, the company said. "This is not a health and safety issue," Monsanto spokesman Chris Horner said. Monsanto, based in St. Louis, Missouri, is the world's leading developer of genetic modifications for corn, soybeans, cotton and canola. The company's technology enables crops to become resistant to insects and tolerant of weed killers. US farmers have largely embraced the developments, particularly in soybeans. But other countries, notably in the European Union, have been slow to approve the products because of questions about how genetic changes in the plants affect humans and animals. And some US critics have been vocal as well. "The study showing problems... is just one of many such alarming results that have been distorted, denied, or covered up," said Jeffrey Smith, the author of a book about Monsanto and its development of biotech crops. "Other GM (genetically modified) rat studies revealed liver problems, potentially pre-cancerous cell growth, damaged immune systems, inhibited organ development, stomach lesions and unexplained deaths," he said. "The technology of inserting genes into crops... is fraught with dangerous, hard-to-detect side-effects." Monsanto spokesman Horner said the anomalies are not outside of a normal statistical range expected in these types of studies. "All the relevant European authorities have looked at this research," he said. "The questions were surrounding statistical issues, not anything substantial to the health of rats." Monsanto has requested approval to import the biotech corn for use in processed foods and derived food products, but the EU's 25 governments are deadlocked over the issue. Critics of biotech food said there are numerous studies beyond Monsanto's internal research that show health concerns tied to those products. Monsanto shares were down 34 cents at $57.66 in early trading on the New York Stock Exchange. Story by Carey Gillam REUTERS NEWS SERVICE Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.